SCHEMBL12428574

SCHEMBL12428574

CNc1ccc(-c2ccc(C(=O)CC(C)(C)C(=O)OC)cc2)cc1F

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 1/20 0.41
ABCB1 P08183 8/20 0.40
GAA P10253 2/20 0.40
ABCC1 P33527 2/20 0.39
TP53 P04637 1/20 0.38
KIF11 P52732 3/20 0.38
DHODH Q02127 1/20 0.36
ERN1 O75460 1/20 0.36
DGAT1 O75907 1/20 0.35
KDM4E B2RXH2 1/20 0.35
LMNA P02545 1/20 0.35
HSD17B10 Q99714 1/20 0.35
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1748028 0.87 CYP17A1 (0.39) CYP17A1ABCB1GAAABCC1TP53
SCHEMBL1748134 0.84 HDAC1 (0.41) CYP17A1ABCB1GAAABCC1KIF11
SCHEMBL1748085 0.76 GAA (0.36) GAATP53ERN1KDM4ELMNA
SCHEMBL595610 0.76 GAA (0.43) GAAKDM4ELMNAHSD17B10SMN1; SMN2
SCHEMBL1747913 0.74 ALDH1A1 (0.45) GAAKDM4ELMNAHSD17B10
SCHEMBL1747936 0.73 ALDH1A1 (0.51) ABCB1GAAKDM4ELMNAHSD17B10
SCHEMBL6032290 0.73 RARB (0.39) ABCB1GAAKIF11NPC1
SCHEMBL1748024 0.73 GSK3B (0.48) GAALMNAHSD17B10NPC1RAB9A
SCHEMBL4225890 0.72 POLB (0.53) GAATP53DGAT1KDM4ELMNA
SCHEMBL1748176 0.71 GAA (0.40) GAAERN1DGAT1LMNAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1633722-B1 PREPARATION AND USE OF ARYL ALKYL ACID DERIVATIVES FOR THE TREATMENT OF OBESITY BAYER HEALTHCARE LLC (US) 2011-08-03 EP disclosed